One of the concurrent sessions - Is the Locus of Medical Research and Innovation Shifting to Asia? - opens May 18 afternoon. Speakers include Jing Cheng, Founder and CEO, CapitalBio Corp.; William A. Haseltine, Chairman and CEO, Haseltine Associates Ltd.; Edison Liu, M.D., Executive Director, Genome Institute of Singapore; Joerg Reinhardt, Head of Pharma Development, Novartis Pharma AG and Zhang Simin, Chairman and CEO, Shenzhen Neptunus Biopharmaceutical Holdings Co. Ltd. The moderator is David Stipp, Senior Writer, FORTUNE. (photos from newsphoto.com.cn)

Speakers at the session

Edison Liu, M.D., Executive Director, Genome Institute of Singapore


Joerg Reinhardt (L) and William A. Haseltine